lobbying_activities: 2148556

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2148556	52f22542-dd19-47f9-a33b-74034852d9f5	Q2	THE D MAJOR GROUP	401103162	ALLERGAN INC (FORMERLY ACTAVIS INC )	2018	second_quarter	CPT	Advocate for Inter Partes Review (IPR) reform concerning pharmaceuticals.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2018-07-17T19:28:41.700000-04:00